TOBACCO REGULATION BEING CONSIDERED BY FDA

被引：0

作者：

MCCARTHY, M

机构：

来源：

LANCET | 1994年 / 343卷 / 8898期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：664 / 664

页数：1

共 50 条

[1] The FDA and tobacco regulation
Curfman, Gregory D.
Morrissey, Stephen
Drazen, Jeffrey M.
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (10): : 1056 - 1057
[2] FDA Regulation of Tobacco
Nitzkin, Joel L.
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19): : 2070 - 2070
[3] FDA tobacco regulation
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (02): : 163 - 163
[4] The FDA and Tobacco Regulation.
Yancy, Clyde
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21): : 2294 - 2294
[5] FDA Regulation of Tobacco: Blessing or Curse for FDA Professionals?
O'Reilly, James T.
FOOD AND DRUG LAW JOURNAL, 2009, 64 (03) : 459 - 472
[6] FDA regulation of tobacco - Pitfalls and possibilities
Brandt, Allan M.
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (05): : 445 - 448
[7] The FDA's regulation of tobacco products
Zieve, AM
FOOD AND DRUG LAW JOURNAL, 1996, 51 (04): : 495 - 500
[8] FDA Regulation of Tobacco Products in the US
Zeller, Mitch
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S98 - S98
[9] A postmarketing safety programme for generic ticlopidine is being considered by the US FDA
Reactions Weekly, 1999, 753 (1) : 2 - 2
[10] US FDA plans improved tobacco regulation
Furlow, Bryant
LANCET RESPIRATORY MEDICINE, 2023, 11 (05): : E48 - E48